Cidara Therapeutics, Inc.
CDTXDelisted Jan 7, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001610618
Cidara Therapeutics, Inc. was delisted on Jan 7, 2026; its insiders filed their last Form 4 on Jan 9, 2026; 255 institutions reported holding it in 13F filings for Q4 2025, worth $7.36B in total; 3 superinvestors held it, including Maverick Capital and Soros Fund Management.
Q1 2023 vs. Q4 2022
How the institutions holding Cidara Therapeutics, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 42 | 54 | +12 |
| Shares | 26.6M | 27.1M | +459.3K (+1.7%) |
| Value | $20.2M | $34.4M | +$14.3M (+70.8%) |
New holders (21)
Institutions that held Cidara Therapeutics, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Schonfeld Strategic Advisors LLC | 666,400 | $846.3K | 0.01% |
| Parkman Healthcare Partners LLC | 600,000 | $762.0K | 0.17% |
| Monashee Investment Management LLC | 369,099 | $468.8K | 0.13% |
| XTX Topco Ltd | 148,835 | $189.0K | 0.04% |
| Two Sigma Investments, LP | 133,500 | $169.5K | 0.00% |
| Susquehanna International Group, LLP | 104,501 | $132.7K | 0.00% |
| Bank of New York Mellon Corp | 74,210 | $94.2K | 0.00% |
| Vontobel Holding Ltd. | 52,841 | $67.1K | 0.00% |
| Advisor Group Holdings, Inc. | 38,900 | $49.4K | 0.00% |
| Group One Trading, L.P. | 31,228 | $39.7K | 0.00% |
| Marshall Wace, LLP | 28,264 | $35.9K | 0.00% |
| Charles Schwab Investment Management Inc | 26,814 | $34.1K | 0.00% |
| Kestra Advisory Services, LLC | 26,134 | $33.2K | 0.00% |
| Simplex Trading, LLC | 19,559 | $24.0K | 0.00% |
| HRT Financial LP | 14,827 | $18.0K | 0.00% |
| Visionary Wealth Advisors | 13,008 | $16.5K | 0.00% |
| Liberty Wealth Management LLC | 12,000 | $15.2K | 0.00% |
| Two Sigma Securities, LLC | 11,592 | $14.7K | 0.00% |
| Pure Financial Advisors, Inc. | 11,500 | $14.6K | 0.00% |
| Spire Wealth Management | 4,000 | $5.08K | 0.00% |
| Stonepine Capital Management, LLC | 1,000 | $1.27K | 0.00% |
Sold out (9)
Institutions that held Cidara Therapeutics, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Millennium Management LLC | 689,917 | $522.0K |
| Citadel Advisors LLC | 301,612 | $228.1K |
| Artal Group S.A. | 224,675 | $170.0K |
| Goldman Sachs Group Inc | 67,097 | $50.7K |
| Money Concepts Capital Corp | 55,000 | $41.6K |
| Level Four Advisory Services, LLC | 27,927 | $21.1K |
| Fisher Asset Management, LLC | 16,500 | $12.0K |
| StoneX Group Inc. | 15,000 | $11.3K |
| ACT Advisors, LLC. | 13,866 | $10.5K |